Forexpan

Hazard statements (CLP)

H315, H318, H412

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

No additional information available

Hazard pictograms

GHS05

Signal word

Danger

Contains

Sodium laureth sulphate

Hazard statements

H315 - Causes skin irritation. H318 - Causes serious eye damage. H412 - Harmful to aquatic life with long lasting effects.

Precautionary statements

P264 - Wash hands thoroughly after handling. P280 - Wear eye protection, protective clothing, protective gloves. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P332+P313 - If skin irritation occurs: Get medical advice/attention. P362+P364 - Take off contaminated clothing and wash it before reuse.

PBT Substances

not relevant – no registration required

vPvB Substances

not relevant – no registration required Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Sodium laureth sulphate (68891-38-3), 2-(2-butoxyethoxy)ethanol (112-34-5), Ethane-1,2- regulation, in accordance with Annex XIII diol (107-21-1), 1-dodecanol (112-53-8), 1-tetradecanol (112-72-1), Morpholine (110-91- 8)(¹) Substance(s) not meeting the vPvB criteria of REACH Sodium laureth sulphate (68891-38-3), 2-(2-butoxyethoxy)ethanol (112-34-5), Ethane-1,2- regulation, in accordance with Annex XIII diol (107-21-1), 1-dodecanol (112-53-8), 1-tetradecanol (112-72-1), Morpholine (110-91- 8)(¹) (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 1 H318 Hazardous to the aquatic environment – Chronic Hazard, H412 Category 3 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available